Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will rexulti be generic?What precautions can be taken to prevent tigecycline overdose fatalities?Can trintellix cause nausea?Is lipitor less effective with iron supplements?What are reliable websites for lipitor generic discounts?
See the DrugPatentWatch profile for trintellix
What's the latest on the Trintellix patent expiration timeline? Trintellix, an antidepressant medication developed by Lundbeck and Forest Laboratories, was approved by the FDA in 2013 for the treatment of major depressive disorder. According to the FDA approval documents [1], the initial patent for the active ingredient, vortioxetine, was set to expire in 2029 [2]. However, due to the Hatch-Waxman Act, generic versions of Trintellix may become available before the patent expires [3]. According to DrugPatentWatch.com [4], several generic drug manufacturers have filed Abbreviated New Drug Applications (ANDAs) with the FDA to produce generic versions of Trintellix. Who is challenging the Trintellix patent? Several generic drug manufacturers, including Mylan, Teva Pharmaceuticals, and Sandoz, have filed ANDAs with the FDA for generic versions of Trintellix [5]. These companies are challenging the Lundbeck and Forest Laboratories patent, seeking to bring generic versions of the medication to market. When can we expect generic versions of Trintellix to arrive? The FDA has not yet approved any generic versions of Trintellix, but the agency is reviewing several ANDAs filed by generic manufacturers. Based on the FDA's approval process, generic versions of Trintellix may become available in 2026 or later, pending a decision from the FDA [6]. What does this mean for patients and prescribers? The arrival of generic versions of Trintellix will provide patients and prescribers with a more affordable option for treating major depressive disorder. However, until the patent expires or generic versions become available, Trintellix will remain a branded medication with a significant price tag. Sources: [1] FDA Approval Letter for Trintellix [2] Trintellix patent expiration date according to FDA documents [3] Hatch-Waxman Act, 21 U.S.C. § 355(j) [4] DrugPatentWatch.com [5] ANDA filings with the FDA for generic versions of Trintellix [6] FDA approval timeline for generic versions of Trintellix
Other Questions About Trintellix :